FDA Grants EUA to Roche’s Tocilizumab Despite Mixed Study Results
The U.S. Food and Drug Administration (FDA) made yet another questionable decision by issuing an emergency use authorization (EUA) for Roche’s IL-6 inhibitor called Actemra/RoActemra…
Tag: Tocilizumab
Dramatic Decline in Indian Demand for Remdesivir & Tocilizumab Evidencing Rapidly Recovering India
What were once hot health care commodities during the pandemic are now laggards as both Remdesivir (Gilead) and Tocilizumab (Roche) barely see shelf movement despite…
University Hospital Ghent-led Nationwide Belgium Study Reveals Rhematic Drugs Like Tocilizumab Fail to Treat COVID-19 Patients
Further evidence suggests rheumatic drugs fail to treat effectively COVID-19 patients, such as the results from a recent Ghent University study in Belgium known as…
Roche’s Actemra (Tocilizumab) Fails to Meet Endpoints in REMDACTA Trial Targeting COVID-19 Pneumonia
Although some studies have evidenced to the contrary, the anti-inflammatory drug called Actemra combined with Veklury (remdesivir) did not lead to reduced hospitalization as has…
Roche’s Tocilizumab Fails to Meet Endpoints in Phase 3 COVACTA Trial, However, Does Cut COVID-19 Death Rate in RECOVERY Trial
The use of an immunosuppressive therapy known as tocilizumab, approved to treat the indication of rheumatoid arthritis, has been tested a number of times at…